Wutah pendapatan taun lumaku: Cyclacel, Inc. (CYCC)

Logo perusahaan publik cyclacel.com (CYCC)

Cyclacel Pharmaceuticals (CYCC) develops precision cancer treatments, competing for capital during early-stage development. The year-over-year revenue dynamics over the last 12 months reflect current market positions, where the value of 0.00 captures the metric level. The issuer's prospects rely on the efficacy of CDK inhibitors in treating solid tumors and leukemia, which determines the future scale of the business.

Cyclacel Pharmaceuticals (CYCC): Wutah pendapatan YoY sajrone 12 wulan kepungkur saka 11.02.2024 nganti 20.02.2024

Cyclacel Pharmaceuticals - rincian analitis lan metrik utama (CYCC)

- rega saham lan target rega konsensus:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:Cyclacel Pharmaceuticals Inc.
Produk merek Cyclacel, Inc.

For Cyclacel Pharmaceuticals (CYCC), which develops therapies for solid tumors and leukemia, revenue dynamics depend critically on the clinical trial stages of new molecules. By analyzing the YoY revenue growth rate over a rolling 12-month period, an investor assesses the percentage change in income over the last four quarters, allowing for the rapid identification of product commercialization trends before the release of official annual reports and confirming the business's financial stability.

Karo sapa Cyclacel Pharmaceuticals saingan

Incyte Pharma - Wutah dodolan YoY sajrone rolas wulan kepungkur|HUTCHMED Corp - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Nuvation Bio Inc.|DAWN: Wutah dodolan YoY (TTM)|Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur Monopar Pharma MNPR|Wutah pendapatan YoY sajrone 12 wulan kepungkur INBX|Wutah pendapatan taun lumaku I-Mab Biopharma IMAB|Wutah pendapatan YoY sajrone 12 wulan kepungkur FENC (Fennec Pharmaceuticals)|HRTX (Heron Therapeutics Inc) - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Nuvectis Pharma, Inc. - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur CHRS (Coherus BioSciences)|Corbus Pharma - Wutah dodolan YoY (TTM)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur CRDF (cardiffoncology.com)|BYSI: Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku BioAtla Corp (BCAB)|Wutah dodolan YoY sajrone rolas wulan kepungkur Lixte Biotechnology Holdings, Inc.|CTXR: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) CLRB|Wutah dodolan YoY (TTM) BioLineRx Corporation (BLRX)|Wutah dodolan YoY sajrone rolas wulan kepungkur Can-Fite BioPharma, Ltd. CANF|APRE (aprea.com) - Wutah dodolan taun lumaku|KZIA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku Silexion Therapeutics|NuCana plc (NCNA) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur Chimerix, Inc|GTHX (g1therapeutics.com) - Wutah dodolan YoY (TTM)|KRON: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Kintara (KTRA)|Wutah pendapatan YoY sajrone 12 wulan kepungkur Oncternal ONCT|Portage Biotech - Wutah pendapatan YoY sajrone 12 wulan kepungkur